Broker rates these 2 top ASX 200 shares as buys in July

Hub24 and ResMed are among this broker's favourites.

| More on:
Person pressing the buy button on a smartphone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Brokers are always on the hunt for opportunities. Ord Minnett has picked out two ASX 200 share ideas
  • ResMed is one of the leading ASX healthcare shares. It aims to help patients with sleep apnea
  • Hub24 is one of Australia’s leading fintech companies

The S&P/ASX 200 Index (ASX: XJO) could be the place to look for shares that are leaders in their industry, while also being good value.

But which ASX shares should investors go for? The broker Ord Minnett has named some companies it thinks are opportunities to buy.

Recent volatility makes it tricky to know which shares are the best value. However, brokers like to name share price targets, which is their best guess about where a share price will be in 12 months.

While a share price target is certainly not a guarantee of returns, it can indicate how much potential an ASX share may have in the broker's eyes.

These two are rated as buys by Ord Minnett and seemingly have good upside potential.

ResMed Inc (ASX: RMD)

ResMed is an expert in helping people with sleep apnea. The company says it has innovative solutions that treat and keep people out of hospital, empowering them to live healthier, higher-quality lives.

It says it has digital health technologies and cloud-connected medical devices that can transform care for people with sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic diseases. It operates in more than 140 countries.

Ord Minnett recently focused on the news that the ASX 200 share will acquire Medifox Dan for approximately US$1 billion. This company specialises in software solutions for professional and non-professional care, therapeutic practices and child, family and youth welfare facilities. It also has digital solutions for modern training and education management.

Medifox Dan made pro forma net revenue of US$83 million in 2021, with pro forma adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) of approximately $35 million.

While Ord Minnett rates ResMed as a buy with a price target of $35, it thought the acquisition price was high considering what's going on globally with the decline of share prices.

At the time of writing, the ResMed share price is up 0.8% at $31.05.

Hub24 Ltd (ASX: HUB)

Hub24 is a platform business in the financial technology (fintech) world. It has different segments including Hub24, Xplore, HUBconnect and Class.

The company boasts that it is Australia's fastest-growing platform provider. Hub24's market share has grown to around 5%, with an ongoing strong share of net flows.

It aims to lead the wealth industry as the best provider of an integrated platform, technology and data solutions.

The ASX 200 share is growing quickly. In the quarter for the three months to 31 March 2022, it saw net inflows of $2.6 billion, which was an increase of 36.4% year on year. Total funds under administration (FUA) was $68.3 billion at 31 March 2022 – platform FUA of $51 billion was up 43.3% year on year.

The financials are showing rapid growth. FY22 first-half platform segment revenue rose 76% to $77.3 million, while underlying net profit after tax (NPAT) went up 103% to $14.2 million.

It's currently rated as a buy by Ord Minnett, with a price target of $30. The broker thinks Hub24 has an attractive long-term future and can continue to achieve attractive inflows.

The Hub24 share price is up 0.59% to $20.41 in early trading on Thursday.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24 Ltd and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended Hub24 Ltd and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Best Shares

A businessman holding a butterfly net looks around hoping to snare a good ASX share investment
Best Shares

Top ASX shares to buy in April 2024

Our Foolish writers are chock-full of stock ideas this month!

Read more »

A smiling young surf life saver at the beach shouts out on a megaphone.
Best Shares

Top ASX shares to buy in March 2024

Shout out for the first day of autumn! Are you letting 2024's ASX gains flow your way?

Read more »

A businessman hugs his computer and smiles.
Best Shares

5 ASX shares to buy and hold forever in your investment portfolio

Here are my five picks for a future-proof ASX share portfolio.

Read more »

Three hikers lift their arms in jubilation as they reach a rocky peak overlooking a sensational view of water and mountains with a blue sky surrounding them.
Best Shares

Top ASX shares to buy in February 2024

The Aussie stock market is scaling new heights. Are you getting in on the action?

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Best Shares

Top 5 most profitable ASX large-cap shares of 2023

These big and bustling companies were the King Kongs of profitability last year.

Read more »

A woman looks internationally at a digital interface of the world.
Best Shares

In a record year for ETFs growth, this ASX crypto fund returned 215%

Crypto and technology ETFs delivered the highest returns for ASX and Cboe Australia investors in 2023.

Read more »

a man with a wide, eager smile on his face holds up three fingers.
Best Shares

3 no-brainer ASX 300 shares I'd buy right now without hesitation

I don't like buying shares near record highs, but I'd make an exception for these three...

Read more »

An older woman clasps her hands with joy, smiling at the news on her computer as she sits at her kitchen bench..
Best Shares

Which had the better year in 2023: Telstra, Woodside or Wesfarmers shares?

We review the share price growth and dividends paid by these popular ASX 200 shares last year.

Read more »